Molecular pathogenesis of Huntington's disease: The role of excitotoxicity

Mahmoud A. Pouladi, Ilya Bezprozvanny, Lynn A. Raymond, Michael R. Hayden

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

This chapter discusses the role of excitotoxicity in the molecular pathogenesis of Huntington's disease (HD). HD is a progressive neurological disorder characterized by involuntary movements, emotional disturbances, and dementia. The underlying genetic lesion is an expansion of a CAG trinucleotide repeat in the HD gene that results in an expanded polyglutamine (polyQ) stretch at the N-terminus of the huntingtin protein (htt). The cardinal neuropathological feature of HD is a selective loss in the striatum of medium-sized spiny neurons. Recent evidence strongly implicates aberrant glutamate signaling, disrupted neuronal calcium handling, and the accompanying excitotoxicity in the pathogenesis of HD. The involvement of excitotoxicity in the pathogenesis of HD was first suggested by rodent studies in which intrastriatal injections of kainic acid (KA) or quinolinic acid (QA, an NMDA receptor agonist) produced lesions that mimicked many of the neurochemical and histopathological features of HD, and was associated with HD-like behavioral deficits. A number of human and animal studies have since identified defects in NMDA and mGluR5 signaling, as well as mitochondrial calcium handling in HD patients and animal models of HD. Together, these studies give rise to a coherent, multifactorial model of mutant huntingtin-mediated alteration of glutamate receptor activity, and calcium signaling as a primary contributor to neuronal degeneration in HD.

Original languageEnglish (US)
Title of host publicationGenetic Instabilities and Neurological Diseases, Second Edition
PublisherElsevier Inc.
Pages251-260
Number of pages10
ISBN (Print)9780123694621
DOIs
StatePublished - 2006

Fingerprint

Huntington Disease
Calcium
Animals
Quinolinic Acid
Trinucleotide Repeats
Affective Symptoms
Calcium Signaling
Kainic Acid
Dyskinesias
Glutamate Receptors
N-Methylaspartate
Nervous System Diseases
N-Methyl-D-Aspartate Receptors
Neurons
Dementia
Glutamic Acid
Rodentia
Animal Models
Genes
Defects

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Pouladi, M. A., Bezprozvanny, I., Raymond, L. A., & Hayden, M. R. (2006). Molecular pathogenesis of Huntington's disease: The role of excitotoxicity. In Genetic Instabilities and Neurological Diseases, Second Edition (pp. 251-260). Elsevier Inc.. https://doi.org/10.1016/B978-012369462-1/50016-8

Molecular pathogenesis of Huntington's disease : The role of excitotoxicity. / Pouladi, Mahmoud A.; Bezprozvanny, Ilya; Raymond, Lynn A.; Hayden, Michael R.

Genetic Instabilities and Neurological Diseases, Second Edition. Elsevier Inc., 2006. p. 251-260.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pouladi, MA, Bezprozvanny, I, Raymond, LA & Hayden, MR 2006, Molecular pathogenesis of Huntington's disease: The role of excitotoxicity. in Genetic Instabilities and Neurological Diseases, Second Edition. Elsevier Inc., pp. 251-260. https://doi.org/10.1016/B978-012369462-1/50016-8
Pouladi MA, Bezprozvanny I, Raymond LA, Hayden MR. Molecular pathogenesis of Huntington's disease: The role of excitotoxicity. In Genetic Instabilities and Neurological Diseases, Second Edition. Elsevier Inc. 2006. p. 251-260 https://doi.org/10.1016/B978-012369462-1/50016-8
Pouladi, Mahmoud A. ; Bezprozvanny, Ilya ; Raymond, Lynn A. ; Hayden, Michael R. / Molecular pathogenesis of Huntington's disease : The role of excitotoxicity. Genetic Instabilities and Neurological Diseases, Second Edition. Elsevier Inc., 2006. pp. 251-260
@inbook{93c6e9086ac5426fbf9533205c0e3f79,
title = "Molecular pathogenesis of Huntington's disease: The role of excitotoxicity",
abstract = "This chapter discusses the role of excitotoxicity in the molecular pathogenesis of Huntington's disease (HD). HD is a progressive neurological disorder characterized by involuntary movements, emotional disturbances, and dementia. The underlying genetic lesion is an expansion of a CAG trinucleotide repeat in the HD gene that results in an expanded polyglutamine (polyQ) stretch at the N-terminus of the huntingtin protein (htt). The cardinal neuropathological feature of HD is a selective loss in the striatum of medium-sized spiny neurons. Recent evidence strongly implicates aberrant glutamate signaling, disrupted neuronal calcium handling, and the accompanying excitotoxicity in the pathogenesis of HD. The involvement of excitotoxicity in the pathogenesis of HD was first suggested by rodent studies in which intrastriatal injections of kainic acid (KA) or quinolinic acid (QA, an NMDA receptor agonist) produced lesions that mimicked many of the neurochemical and histopathological features of HD, and was associated with HD-like behavioral deficits. A number of human and animal studies have since identified defects in NMDA and mGluR5 signaling, as well as mitochondrial calcium handling in HD patients and animal models of HD. Together, these studies give rise to a coherent, multifactorial model of mutant huntingtin-mediated alteration of glutamate receptor activity, and calcium signaling as a primary contributor to neuronal degeneration in HD.",
author = "Pouladi, {Mahmoud A.} and Ilya Bezprozvanny and Raymond, {Lynn A.} and Hayden, {Michael R.}",
year = "2006",
doi = "10.1016/B978-012369462-1/50016-8",
language = "English (US)",
isbn = "9780123694621",
pages = "251--260",
booktitle = "Genetic Instabilities and Neurological Diseases, Second Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Molecular pathogenesis of Huntington's disease

T2 - The role of excitotoxicity

AU - Pouladi, Mahmoud A.

AU - Bezprozvanny, Ilya

AU - Raymond, Lynn A.

AU - Hayden, Michael R.

PY - 2006

Y1 - 2006

N2 - This chapter discusses the role of excitotoxicity in the molecular pathogenesis of Huntington's disease (HD). HD is a progressive neurological disorder characterized by involuntary movements, emotional disturbances, and dementia. The underlying genetic lesion is an expansion of a CAG trinucleotide repeat in the HD gene that results in an expanded polyglutamine (polyQ) stretch at the N-terminus of the huntingtin protein (htt). The cardinal neuropathological feature of HD is a selective loss in the striatum of medium-sized spiny neurons. Recent evidence strongly implicates aberrant glutamate signaling, disrupted neuronal calcium handling, and the accompanying excitotoxicity in the pathogenesis of HD. The involvement of excitotoxicity in the pathogenesis of HD was first suggested by rodent studies in which intrastriatal injections of kainic acid (KA) or quinolinic acid (QA, an NMDA receptor agonist) produced lesions that mimicked many of the neurochemical and histopathological features of HD, and was associated with HD-like behavioral deficits. A number of human and animal studies have since identified defects in NMDA and mGluR5 signaling, as well as mitochondrial calcium handling in HD patients and animal models of HD. Together, these studies give rise to a coherent, multifactorial model of mutant huntingtin-mediated alteration of glutamate receptor activity, and calcium signaling as a primary contributor to neuronal degeneration in HD.

AB - This chapter discusses the role of excitotoxicity in the molecular pathogenesis of Huntington's disease (HD). HD is a progressive neurological disorder characterized by involuntary movements, emotional disturbances, and dementia. The underlying genetic lesion is an expansion of a CAG trinucleotide repeat in the HD gene that results in an expanded polyglutamine (polyQ) stretch at the N-terminus of the huntingtin protein (htt). The cardinal neuropathological feature of HD is a selective loss in the striatum of medium-sized spiny neurons. Recent evidence strongly implicates aberrant glutamate signaling, disrupted neuronal calcium handling, and the accompanying excitotoxicity in the pathogenesis of HD. The involvement of excitotoxicity in the pathogenesis of HD was first suggested by rodent studies in which intrastriatal injections of kainic acid (KA) or quinolinic acid (QA, an NMDA receptor agonist) produced lesions that mimicked many of the neurochemical and histopathological features of HD, and was associated with HD-like behavioral deficits. A number of human and animal studies have since identified defects in NMDA and mGluR5 signaling, as well as mitochondrial calcium handling in HD patients and animal models of HD. Together, these studies give rise to a coherent, multifactorial model of mutant huntingtin-mediated alteration of glutamate receptor activity, and calcium signaling as a primary contributor to neuronal degeneration in HD.

UR - http://www.scopus.com/inward/record.url?scp=70450158061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450158061&partnerID=8YFLogxK

U2 - 10.1016/B978-012369462-1/50016-8

DO - 10.1016/B978-012369462-1/50016-8

M3 - Chapter

AN - SCOPUS:70450158061

SN - 9780123694621

SP - 251

EP - 260

BT - Genetic Instabilities and Neurological Diseases, Second Edition

PB - Elsevier Inc.

ER -